L
Leben Salud | Fundacion Medica de Rio Negro y Neuquen
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Bemarituzumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 1 total trial
Locations recently updated
The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.
Enrolling
Solid Tumors
Drug: Bemarituzumab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems